Fractional genomic alteration detected by array-based comparative genomic hybridization independently predicts survival after hepatic resection for metastatic colorectal cancer

Clinical Cancer Research

Volumn 11, Issue 5, 2005, Pages 1791-1797

  Mehta, Kshama R ^a   Nakao, Kentaro ^c   Zuraek, Marlene B ^b   Ruan, Daniel T ^b   Bergsland, Emily K ^a   Venook, Alan P ^a   Moore, Dan H ^b   Tokuyasu, Taku A ^a   Jain, Ajay N ^a   Warren, Robert S ^b   Terdiman, Jonathan P ^a   Waldman, Frederic M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME; CHROMOSOME 20; CHROMOSOME 7; COLORECTAL CANCER; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA MICROARRAY; FEMALE; GENOME ANALYSIS; HUMAN; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLONING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

AGED; CHROMOSOMES, ARTIFICIAL, BACTERIAL; COLORECTAL NEOPLASMS; DNA, NEOPLASM; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENOME; HUMANS; IN SITU HYBRIDIZATION; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 20144389795     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1418     Document Type: Article

References (56)

1. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-18.
2. Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 1996;77:1254-62.
3. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-48.
4. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
5. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
6. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;386:623-7.
7. Olschwang S, Hamelin R, Laurent-Puig P, et al. Alternative genetic pathways in colorectal carcinogenesis. Proc Natl Acad Sci U S A 1997;94:12122-7.
8. Leichman CG. Predictive and prognostic markers in gastrointestinal cancers. Curr Opin Oncol 2001;13:291-9.
9. Anderson GR, Brenner BM. Molecular markers in colorectal cancer. Lancet 2002;359:183-4.
10. Kahlenberg MS, Sullivan JM, Witmer DD, Petrelli NJ. Molecular prognostics in colorectal cancer. Surg Oncol 2003;12:173-86.
11. Kastrinakis WV, Ramchurren N, Maggard M, Steele G Jr, Summerhayes IC. K-ras status does not predict successful hepatic resection of colorectal cancer metastasis. Arch Surg 1995;130:9-14.
12. Belluco C, Guillem JG, Kemeny N, et al. p53 nuclear protein overexpression in colorectal cancer, a dominant predictor of survival in patients with advanced hepatic metastases. J Clin Oncol 1996;14:2696-701.
13. Kochhar R, Halling KC, McDonnell S, et al. Allelic imbalance and microsatellite instability in resected Duke's D colorectal cancer. Diagn Mol Pathol 1997;6:78-84.
14. Heisterkamp J, van Bommel J, Hop WC, Tilanus HW, Zondervan PE, Uzermans JN. P53 overexpression in colorectal metastases confined to the liver and outcome of liver resection. Hepatogastroenterology 1999;46:3109-14.
15. Crowe PJ, Yang JL, Bemey CR, et al. Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer. World J Surg 2001;25:996-1001.
16. Saw RP, Koorey D, Painter D, Gallagher PJ, Solomon MJ. p53, DCC and thymidylate synthase as predictors of survival after resection of hepatic metastases from colorectal cancer. Br J Surg 2002;89:1409-15.
17. Gonen M, Hummer A, Zervoudakis A, et al. Thymidylate synthase expression in hepatic tumors is a predictor of survival and progression in patients with resectable metastatic colorectal cancer. J Clin Oncol 2003;21:406-12.
18. Pollack JR, Perou CM, Alizadeh AA, et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999;23:41-6.
19. Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays. Nat Genet 1998;20:207-11.
20. Snijders AM, Nowak N, Segraves R, et al. Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet 2001;29:263-4.
21. Albertson DG, Ylstra B, Segraves R, et al. Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogene. Nat Genet 2000;25:144-6.
22. Cheung VG, Nowak N, Jang W, et al. Integration of cytogenetic landmarks into the draft sequence of the human genome. Nature 2001;409:953-8.
23. Collins C, Volik S, Kowbel D, et al. Comprehensive genome sequence analysis of a breast cancer amplicon. Genome Res 2001;11:1034-42.
24. Wilhelm M, Veltman JA, Olshen AB, et al. Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res 2002;62:957-60.
25. Veltman JA, Fridlyand J, Pejavar S, et al. Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 2003;63:2872-80.
26. Nakao K, Mehta KR, Fridlyand J, et al. High-resolution analysis of DNA copy number alterations in colorectal cancer by array-based comparative genomic hybridization. Carcinogenesis 2004;25:1345-57.
27. Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997;57:300-3.
28. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
29. Tibshirani R, Hastie T, Narasimhan B, Chu G. Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci U S A 2002;99:6567-72.
30. Olshen AB, Jain AN. Deriving quantitative conclusions from microarray expression data. Bioinformatics 2002;18:961-70.
31. Arribas R, Capella G, Tortola S, et al. Assessment of genomic damage in colorectal cancer by DNA fingerprinting: prognostic applications. J Clin Oncol 1997;15:3230-40.
32. Weber JC, Schneider A, Rohr S, et al. Analysis of allelic imbalance in patients with colorectal cancer according to stage and presence of synchronous liver metastases. Ann Surg 2001;234:795-802.
33. De Angelis PM, Stokke T, Beigi M, Mjaland O, Clausen OP. Prognostic significance of recurrent chromosomal aberrations detected by comparative genomic hybridization in sporadic colorectal cancer. Int J Colorectal Dis 2001;16:38-45.
34. Zhou W, Goodman SN, Galizia G, et al. Counting alleles to predict recurrence of early-stage colorectal cancers. Lancet 2002;359:219-25.
35. Bazan V, Migliavacca M, Zanna I, et al. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study. J Cancer Res Clin Oncol 2002;128:650-8.
36. Choi SW, Lee KJ, Bae YA, et al. Genetic classification of colorectal cancer based on chromosomal loss and microsatellite instability predicts survival. Clin Cancer Res 2002;8:2311-22.
37. Diep CB, Thorstensen L, Meling GI, Skovlund E, Rognum TO, Lothe RA. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients. J Clin Oncol 2003;21:820-9.
38. Knosel T, Schluns K, Stein U, et al. Genetic imbalances with impact on survival in colorectal cancer patients. Histopathology 2003;43:323-31.
39. Scott CA, Desinan L, Avellini C, et al. DNA index shift with disease progression in colorectal adenocarcinoma: a morphological and flow cytometric study. Hum Pathol 1998;29:482-90.
40. Flyger HL, Larsen JK, Nielsen HJ, Christensen IJ. DNA ploidy in colorectal cancer, heterogeneity within and between tumors and relation to survival. Cytometry 1999;38:293-300.
41. Geido E, Sciutto A, Rubagotti A, et al. Combined DNA flow cytometry and sorting with k-ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer. Cytometry 2002;50:216-24.
42. Rooney PH, Boonsong A, McKay JA, et al. Colorectal cancer genomics: evidence for multiple genotypes which influence survival. Br J Cancer 2001;85:1492-8.
43. Risques RA, Moreno V, Ribas M, Marcuello E, Capella G, Peinado MA. Genetic pathways and genome-wide determinants of clinical outcome in colorectal cancer. Cancer Res 2003;63:7206-14.
44. Tollenaar RA, Bonsing BA, Kuipers-Dijkshoom NJ, et al. Evidence of clonal divergence in colorectal carcinoma. Cancer 1997;79:1304-14.
45. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 2001;61:818-22.
46. Hermsen M, Postma C, Baak J, et al. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 2002;123:1109-19.
47. Diep CB, Teixeira MR, Thorstensen L, et al. Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients. Mol Cancer 2004;3:6-10.
48. Cahill DP, Kinzler KW, Vogelstein B, Lengauer C. Genetic instability and Darwinian selection in tumours. Trends Cell Biol 1999;9:M57-60.
49. Remvikos Y, Muleris M, Salmon RJ, Dutrillaux B. Colorectal carcinogenesis: from chromosomal evolution pathways to molecular pathogenesis. Cancer Genet Cytogenet 1997;93:63-73.
50. Tsao JL, Tavare S, Salovaara R, Jass JR, Aaltonen LA, Shibata D. Colorectal adenoma and cancer divergence. Evidence of multilineage progression. Am J Pathol 1999;154:1815-24.
51. Loukola A, Salovaara R, Kristo P, et al. Microsatellite instability in adenomas as a marker for hereditary nonpolyposis colorectal cancer. Am J Pathol 1999;155:1849-53.
52. Lindgren G, Liljegren A, Jaramillo E, Rubio C, Lindblom A. Adenoma prevalence and cancer risk in familial nonpolyposis colorectal cancer. Gut 2002;50:228-34.
53. Rijcken FEM, Hollema H, Kleibeuker JH. Proximal adenomas in hereditary nonpolyposis colorectal cancer are prone to rapid malignant transformation. Gut 2002;50:382-6.
54. Sankila R, Aaltonen LA, Järvinen HJ, Mecklin JP. Better survival rates in patients with MLH1-associated hereditary colorectal cancer. Gastroenterology 1996;110:682-7.
55. Myrhøj T, Bisgaard ML, Bernstein I, Svendsen LB, Søndergaard JO, Bülow S. Hereditary non-polyposis colorectal cancer: clinical features and survival. Results from the Danish HNPCC register. Scand J Gastroenterol 1997;32:572-6.
56. Watson P, Lin KM, Rodriguez-Bigas MA, et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer 1998;83:259-66.